Results 91 to 100 of about 6,226 (154)

Ultra-High-Dose Intracoronary Diltiazem as a Last-Resort Strategy for Refractory No-Reflow. [PDF]

Acta Cardiol Sin
Guvenc TS, Velibey Y, Guvenc RC.
europepmc   +1 more source

Development and validation of a clinical model for predicting 90-day outcomes after endovascular therapy with adjunctive tirofiban in acute ischemic stroke. [PDF]

Front Neurol
Du M, Yuan H, Zhang T, Luan Z, Wei H, Sun Z, Liu D, Liang Z.   +7 more
europepmc   +1 more source

Case Report: Severe thrombocytopenia in the context of concomitant tirofiban and ibuprofen use: does ibuprofen matter? [PDF]

Front Cardiovasc Med
Zhu J, Chen C, Zhu C, Sun L.
europepmc   +1 more source

Real-world safety of tirofiban: a disproportionality analysis using data from FAERS and WHO-VigiAccess. [PDF]

Front Pharmacol
Li J, Wang F, Zhong L, Zhang L, Ji K, Zheng Y.   +5 more
europepmc   +1 more source

Concurrent Acute Ischemic Stroke and Acute Coronary Syndrome: A Case Report on Sequential Endovascular Intervention and Peri-Procedural Antiplatelet Management with Tirofiban. [PDF]

Int Med Case Rep J
Luo H, Zhao Z, Chen Y, Li S, Wu X, Cao X, Liu X, Liu S, Liu B.   +8 more
europepmc   +1 more source

Introducing the Caliber-Flow Status Scale (CFSS): a novel tool for assessing covered cortical branch status after flow diverter treatment of middle cerebral artery aneurysms. [PDF]

J Neurointerv Surg
Nawka MT, Zainal IA, Manceau PF, Soize S, Pierot L.   +4 more
europepmc   +1 more source

Intracoronary adjunctive therapies for ST-elevation myocardial infarction: a network meta-analysis of trials. [PDF]

Eur Heart J Cardiovasc Pharmacother
Laborante R, Bianchini E, Ciliberti G, Paglianiti DA, Filomia S, Bianchini F, Galli M, Biondi-Zoccai G, Serruys PW, Crea F, Patti G, Savarese G, Trani C, Burzotta F, D'Amario D.   +14 more
europepmc   +1 more source